Aldeyra Therapeutics, Inc. - 8-K Filing

Aldeyra Therapeutics receives Nasdaq deficiency notice due to common stock closing price falling below $1.00 for 30 consecutive business days. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing)

SEC EDGAR ·

Tickers: $ALDX

Read the full article at SEC EDGAR

More Regulatory news